Hantz Financial Services’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Buy
+14
New +$1.09K ﹤0.01% 2381

Other funds holding BBIO

Hantz Financial Services's BBIO Position: Q3 2026 in Review

Hantz Financial Services opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 14 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2381 among its holdings.

471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Hantz Financial Services held 14 shares of BridgeBio Pharma worth $1K as of Q3 2026.
  • BridgeBio Pharma was a new Hantz Financial Services position in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Hantz Financial Services's portfolio in Q3 2026, its #2381 holding.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Hantz Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.